Facebook
Linkedin
Twitter
Home
News
COP Climate Change
COVID-19
Government
Finance
Workplace
Health & Social Care
Coronavirus (COVID-19)
Cancer Research
Diseases & Conditions
Mental Health
Pharma
Women’s Health
Environment
Circular Economy
Sustainable Development
Agriculture
Energy
Research & Innovation
Transport
Education
Technology
Artificial Intelligence
Digital Transformation
Publications
Academic Articles
Special Reports
Government
Health & Social Care
Environment
Agriculture
Energy
Research & Innovation
Transport
Education
Finance
HR & Training
Technology
Stakeholders
eBooks
Asia Analysis
North America Analysis
Subscribe
Search
Open Access Government
Open Access Government
Contact Us
About Us
Editors
Our Audience
Marketing Information Pack
Prestige Contributors
Testimonials
Open Access Government
Open Access Government
Linkedin
Twitter
Facebook
Instagram
Home
News
Publications
Academic Articles
Special Reports
Stakeholders
eBooks
Subscribe
Agriculture
Education
Energy
Environment
COP Climate Change
Circular Economy
Sustainable Development
Government
Finance
Workplace
Health
Cancer Research
Diseases & Conditions
Mental Health
Pharma
Women’s Health
COVID-19
Research
Technology
Artificial Intelligence
Digital Transformation
Transport
North America
Asia
Search
Home
Open Access News
SH Cannabis Education Solutions
SH Cannabis Education Solutions
Subscribe to Updates
The FDA’s 2020 Cannabis policy
Pharma
March 27, 2020
Here, Ann Allworth discusses what lies ahead for the FDA’s 2020 Cannabis policy and highlights discrepancies in their thinking.
No posts to display
Advertisements
Latest Academic Articles
The latest academic articles from key research stakeholders
Visit Article Archive
Targeting the brain for the treatment of type 1 diabetes
Health
April 11, 2025
Sudden death is the most catastrophic manifestation of heart disease
Health
April 11, 2025
Fighting foreign information manipulation and interference
Social Sciences
April 10, 2025
Horticulture: Hormonal therapy for grapevines
Agribusiness
April 2, 2025